Enovix (NASDAQ:ENVX) Issues Q3 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its third quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of -0.170–0.130 for the period, compared to the consensus earnings per share estimate of -0.150. The company issued revenue guidance of $9.0 million-$10.0 million, compared to the consensus revenue estimate of $10.3 million.

Analysts Set New Price Targets

A number of research firms have recently issued reports on ENVX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Craig Hallum set a $7.00 target price on Enovix in a report on Thursday. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Oppenheimer reduced their price objective on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a research report on Thursday, May 14th. Finally, B. Riley Financial decreased their price objective on shares of Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday. Six investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $12.32.

Enovix Stock Down 6.3%

ENVX opened at $4.43 on Friday. The stock has a fifty day moving average of $5.39 and a 200-day moving average of $5.88. The company has a market capitalization of $966.40 million, a P/E ratio of -5.47 and a beta of 2.32. Enovix has a fifty-two week low of $3.67 and a fifty-two week high of $14.21. The company has a debt-to-equity ratio of 2.14, a quick ratio of 10.65 and a current ratio of 10.97.

Enovix (NASDAQ:ENVX) last released its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative net margin of 473.89% and a negative return on equity of 60.98%. The business had revenue of $9.02 million for the quarter, compared to the consensus estimate of $8.43 million. During the same period in the prior year, the company posted ($0.13) earnings per share. Enovix’s revenue was up 20.8% compared to the same quarter last year. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, equities analysts expect that Enovix will post -0.79 EPS for the current year.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported second-quarter adjusted earnings of a $0.13-per-share loss, better than the $0.15 loss analysts expected. Revenue reached $9.02 million, up 20.8% year over year and above estimates of approximately $8.43 million. Enovix Q2 earnings report
• Positive Sentiment: Analyst sentiment remains bullish. Cantor Fitzgerald reaffirmed its “overweight” rating and set a $25 price target, while B. Riley maintained a “buy” rating despite reducing its target from $10 to $9. Both targets imply substantial upside from recent trading levels. Analyst ratings reported by Benzinga
• Neutral Sentiment: Management highlighted potential demand from smartphones, wearables and defense markets on the earnings call. These opportunities could support future growth, but they depend on successful production expansion and customer adoption. Enovix Q2 earnings call transcript
• Negative Sentiment: Third-quarter revenue guidance of $9 million to $10 million came in below the $10.3 million analyst consensus, raising concerns about near-term growth. EPS guidance of a $0.17-to-$0.13 loss also confirms that Enovix remains unprofitable. Enovix second-quarter results
• Negative Sentiment: The stock fell despite the earnings beat, suggesting investors are prioritizing the revenue outlook and ongoing commercialization risks over the modest EPS outperformance. Enovix continues to report deeply negative profitability metrics, including a net margin near negative 500%.

Institutional Investors Weigh In On Enovix

Several institutional investors have recently made changes to their positions in ENVX. Private Advisor Group LLC increased its stake in Enovix by 2.7% during the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after acquiring an additional 1,242 shares during the period. Parallel Advisors LLC lifted its position in shares of Enovix by 51.9% during the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock valued at $39,000 after acquiring an additional 1,342 shares during the period. Equitable Holdings Inc. grew its holdings in shares of Enovix by 10.9% during the 3rd quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock worth $137,000 after purchasing an additional 1,342 shares in the last quarter. Mariner LLC increased its position in shares of Enovix by 3.4% in the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock worth $582,000 after purchasing an additional 1,921 shares during the period. Finally, Federation des caisses Desjardins du Quebec increased its position in shares of Enovix by 2.5% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 80,853 shares of the company’s stock worth $591,000 after purchasing an additional 1,950 shares during the period. 50.92% of the stock is currently owned by institutional investors.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.